Synthetic biology company taking major steps in worldwide effort to put a stop to the SARS-CoV-2 (formerly known as 2019-nCoV) outbreak, including co-funding purchases of BioXp™ 3200 System. SGI-DNA is enabling researchers to quickly print DNA required to discover vaccines and therapeutics. SGI-DNA, creators of the BioXp™ 3200 System and Gibson Assembly® Reagents, announces a focused […]
HELSINKI, Finland – Euformatics partners with bio.logis to enable laboratories using its tertiary analysis platform to provide patients with pharmacogenomic dosing recommendations. While being the topic of countless talks at conferences about personalized medicine for more than a decade, there are encouraging signs, indicating that pharmacogenomic testing is finally finding its way into clinical care. […]
SAN FRANCISCO, Calif.– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it has received ISO 27001:2013 certification for its Information Security Management System (ISMS). ISO 27001:2013 is an information security standard published by the International Organization for Standardization (ISO), the world’s […]
This Partnership is Based on International Reach, Clinical Utility, Data Generation and Talent Development The University of Melbourne and Illumina, Inc. one of the world’s leading biotech companies, announced a partnership that will enhance Melbourne’s reputation as a world class Biomedical Precinct. The partnership will focus on genomics based biomedical research and innovation in the […]
Paris ‐ Stilla Technologies, a leading provider of pioneering digital PCR (dPCR) solutions for high‐precision genetic analysis, has just raised €20 million ($22 million) in a Series B funding round that brought in a new investor, the Chinese group TUS‐Holdings, alongside the participation of existing investors Illumina Ventures, Kurma Partners, LBO France, Paris Saclay Seed […]
SAN DIEGO – TriLink BioTechnologies®, a Maravai LifeSciences company and a leader in the production of nucleic acids for research, diagnostics and therapeutics applications, announced today the addition of two key executives to its leadership team. Ray Kaczmarek joins TriLink as senior vice president of GMP Operations. Kaczmarek, who has over 20 years of experience […]
DUBLIN, Ireland, and VIENNA, Austria: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Aelian Biotechnology (“Aelian”) today announced the signing of a license agreement granting Aelian access to ERS Genomics’ CRISPR/Cas9 patent portfolio, to support Aelian’s commercial functional genomic screening platform. Aelian […]
DUBLIN, Ireland – ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property held by Dr. Emmanuelle Charpentier, announced today that the European Patent Office (EPO) has rejected arguments filed in opposition to European patent No. EP2800811 jointly held by Dr. Charpentier, the Regents of the University of California, and […]
NEW YORK — Enzo Biochem, Inc. (NYSE:ENZ) (the “Company”) today disclosed that Harbert Discovery Fund, LP (“Harbert”) filed a lawsuit against the Company and the members of its board of directors (“Board”) in the U.S. District Court for the Southern District of New York. Enzo commented as follows: “We are disappointed but not surprised by […]
Dr. Denis Zaccarin Succeeds Phillips to Lead Research and Development MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that Michael Phillips has decided to retire from his role as the company’s Senior Vice President of Research and Development as of […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
